Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Traws Pharma, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 22 | 1 | 28 | +7 |
| Shares | 3.42M | 87.3K | 3.62M | +288.5K (+8.7%) |
| Value | $3.86M | $98.6K | $6.62M | +$2.86M (+76.0%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Traws Pharma, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dauntless Investment Group, LLC | 416,998 | $763.1K | 2.14% |
| Palumbo Wealth Management LLC | 61,175 | $112.0K | 0.03% |
| Vanguard Capital Management LLC | 55,193 | $101.0K | 0.00% |
| Vanguard Fiduciary Trust Co | 31,804 | $58.2K | 0.00% |
| Jane Street Group, LLC | 21,241 | $38.9K | 0.00% |
| Lynx1 Capital Management LP | 15,078 | $27.6K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,964 | $7.25K | 0.00% |
| Morgan Stanley | 3,729 | $6.82K | 0.00% |
| Vanguard Global Advisers, LLC | 262 | $479 | 0.00% |
| Cassaday & Co Wealth Management LLC | 11 | $21 | 0.00% |
| Jones Financial Companies LLLP | 2 | $4 | 0.00% |
| Northwestern Mutual Wealth Management Co | 2 | $4 | 0.00% |
| Caitong International Asset Management Co., Ltd | 2 | $4 | 0.00% |
| Royal Bank of Canada | 6 | $0 | 0.00% |
Sold out (7)
Institutions that held Traws Pharma, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Seven Fleet Capital Management LP | 49,260 | $55.7K |
| XTX Topco Ltd | 42,210 | $47.7K |
| Citadel Advisors LLC | 24,819 | $28.0K |
| Susquehanna International Group, LLP | 14,197 | $16.0K |
| Bank of America Corp | 113 | $128 |
| Advisor Group Holdings, Inc. | 8 | $9 |
| Citigroup Inc | 1 | $1 |
Not filed for Q1 2026 yet (1)
Institutions that held Traws Pharma, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 87,259 | $98.6K |